Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model

Exclusion Criteria

• •1. Tandem transplantation or multiple transplantations;
• •2. Patients who are allergic to or cannot tolerate ruxolitinib;
• •3. Mental or other medical conditions that make the patients unable to comply with the research treatment and monitoring requirements;
• •4. Patients who are pregnant or cannot take appropriate contraceptive measures during treatment;
• •5. Patients who are ineligible for the study due to other factors, or will bear great risk if participating in the study.